AYR Wellness Updates Delay of Q1 2025 Interim Filings

1.1 min readPublished On: June 18th, 2025By

LOS ANGELES- AYR Wellness Inc. announced that it did not complete the filing of its interim financial statements, management’s discussion and analysis, and related CEO and CFO certificates for the three-month period ended March 31, 2025, by the anticipated June 13, 2025 deadline. The delay stems from ongoing negotiations with creditors and the assessment of the appropriate accounting classifications of certain debt obligations under discussion with a committee of its senior lenders. These efforts form part of a broader strategic review process evaluating capital-structure alternatives and other options to address upcoming payment obligations and support execution of the company’s long-term plan.

On June 6, 2025, the Ontario Securities Commission issued a failure-to-file cease-trade order under National Policy 12-307. The order prohibits all trading in AYR’s securities across Canadian jurisdictions and has suspended the company’s securities from trading on the Canadian Securities Exchange. The cease-trade order will remain in effect until AYR completes its interim filings and satisfies all exchange requirements.

AYR is working to finalize and file the outstanding documents as soon as possible and will provide a further update on the anticipated timing by June 27, 2025, or sooner if the filings are completed before that date. The company does not expect the cease-trade order to affect its ability to continue normal operations

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!